OTC Drug Labelling
This article was originally published in SRA
US FDA wants stronger warnings on acetaminophen and NSAIDs
You may also be interested in...
STADA Strengthens Specialty Partnership Role Via US Filing
Antoine Marchal, Franchise Head PCR Core Labs - BA Molecular Diagnostics at Qiagen outlines how NeuModx will strengthen its position in the infectious disease space.
Licensing agreements and bolt-on acquisitions to strengthen its R&D pipeline are still in Bayer’s sights as the COVID-19 pandemic and currency devaluations have led to the need for job cuts and substantial cost savings at the big pharma company.